United Therapeutics Corporation announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of Directors. Ms. Malcolm was elected by the company?s shareholders at its annual meeting held on June 26, 2024. Ms. Malcolm is an accomplished leader in health policy, public health, and health care finance and delivery.

She has demonstrated a career-long dedication to improving the health of the public and the care of complex populations. In recognition of her many accomplishments, in February 2024 the American Medical Association (AMA) presented Ms. Malcolm with the AMA Award for Outstanding Government Service. Ms. Malcolm was twice Minnesota?s Commissioner of Health under three governors representing two political parties from 1999 to 2003 and from 2018 to 2023.

During her tenure, Ms. Malcolm earned a national reputation as one of the first health care leaders to highlight health disparities and the impact of social determinants of health. As Health Commissioner during the COVID-19 pandemic, she also played an instrumental and visible role in educating the public, creating dynamic and user-friendly systems for sharing COVID-19 data with the people of Minnesota, and rapidly expanding testing capacity. Ms. Malcolm also has significant healthcare operational experience, having served as a vice president of the Allina Health system, and as CEO of the Courage Center, a leading provider of rehabilitation and health services for people with disabilities.

Ms. Malcolm received a bachelor?s degree in philosophy and psychology from Dartmouth College. Ms. Malcolm filled the Board seat previously held by Professor Katherine Klein, who did not stand for re-election at the company?s 2024 Annual Meeting of Shareholders.